Oxford Nanopore Technologies (LON:ONT - Get Free Report)'s stock had its "outperform" rating reissued by equities researchers at Royal Bank Of Canada in a research note issued to investors on Wednesday,London Stock Exchange reports. They currently have a GBX 225 target price on the stock. Royal Bank Of Canada's target price would indicate a potential upside of 93.81% from the stock's previous close.
ONT has been the subject of several other reports. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Oxford Nanopore Technologies from GBX 210 to GBX 225 and gave the company a "buy" rating in a report on Thursday, January 22nd. Berenberg Bank reissued a "buy" rating and set a GBX 250 price objective on shares of Oxford Nanopore Technologies in a report on Thursday, January 22nd. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of GBX 218.60.
Get Our Latest Stock Analysis on ONT
Oxford Nanopore Technologies Stock Up 2.8%
Oxford Nanopore Technologies stock traded up GBX 3.19 during trading hours on Wednesday, hitting GBX 116.09. The stock had a trading volume of 1,875,387 shares, compared to its average volume of 9,910,396. The company has a quick ratio of 6.01, a current ratio of 3.56 and a debt-to-equity ratio of 8.96. The stock has a market capitalization of £1.12 billion, a P/E ratio of -7.69 and a beta of 0.88. Oxford Nanopore Technologies has a 12-month low of GBX 104 and a 12-month high of GBX 224.80. The stock's 50-day moving average price is GBX 123.94 and its 200-day moving average price is GBX 134.54.
Oxford Nanopore Technologies (LON:ONT - Get Free Report) last issued its earnings results on Monday, March 2nd. The company reported GBX (15.10) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative return on equity of 29.43% and a negative net margin of 64.85%.
Insider Transactions at Oxford Nanopore Technologies
In related news, insider Nick Keher sold 22,993 shares of the business's stock in a transaction that occurred on Tuesday, April 14th. The shares were sold at an average price of GBX 108, for a total transaction of £24,832.44. Insiders have purchased 498 shares of company stock worth $59,939 in the last three months. Insiders own 2.53% of the company's stock.
Oxford Nanopore Technologies Company Profile
(
Get Free Report)
Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oxford Nanopore Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.
While Oxford Nanopore Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.